Agent for Ameliorating Chronic Obstructive Pulmonary Disease

Abstract

This invention provides a safe and effective agent for ameliorating chronic obstructive pulmonary disease (COPD) that has both a bronchodilator effect and an anti-inflammatory effect. The agent for ameliorating chronic obstructive pulmonary disease contains mepenzolate bromide as an active ingredient. More preferably the mode of administration of the agent for ameliorating chronic obstructive pulmonary disease is airway administration or inhalation administration, and furthermore the mode of administration thereof is oral administration or rectal administration. This invention is a safe and effective agent for ameliorating chronic obstructive pulmonary disease (COPD) that has both a bronchodilator effect and an anti-inflammatory effect of mepenzolate bromide.

1 . An agent for ameliorating chronic obstructive pulmonary disease, comprising mepenzolate bromide as an active ingredient. 
     
     
         2 . The agent for ameliorating chronic obstructive pulmonary disease according to  claim 1 , wherein a mode of administration is airway administration or inhalation administration. 
     
     
         3 . The agent for ameliorating chronic obstructive pulmonary disease according to  claim 1 , wherein a mode of administration is oral administration. 
     
     
         4 . The agent for ameliorating chronic obstructive pulmonary disease according to  claim 1 , wherein a mode of administration is rectal administration.